SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001731122-20-000447
Filing Date
2020-05-07
Accepted
2020-05-07 16:32:06
Documents
39
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q e1894_10q.htm 10-Q 625903
2 EXHIBIT 31.1 e1894_31-1.htm EX-31.1 8247
3 EXHIBIT 31.2 e1894_31-2.htm EX-31.2 8543
4 EXHIBIT 32.1 e1894_32-1.htm EX-32.1 7969
5 GRAPHIC image_001.jpg GRAPHIC 96394
6 GRAPHIC image_002.jpg GRAPHIC 82806
  Complete submission text file 0001731122-20-000447.txt   2353437

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE avxl-20200331.xml EX-101.INS 314672
8 XBRL SCHEMA FILE avxl-20200331.xsd EX-101.SCH 24463
9 XBRL CALCULATION FILE avxl-20200331_cal.xml EX-101.CAL 23633
10 XBRL DEFINITION FILE avxl-20200331_def.xml EX-101.DEF 75894
11 XBRL LABEL FILE avxl-20200331_lab.xml EX-101.LAB 180362
12 XBRL PRESENTATION FILE avxl-20200331_pre.xml EX-101.PRE 125426
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 20856984
SIC: 8731 Services-Commercial Physical & Biological Research